Burning Rock Biotech Files 2025 Annual Report
Ticker: BNR · Form: 20-F · Filed: Apr 28, 2026 · CIK: 0001792267
| Field | Detail |
|---|---|
| Company | Burning Rock Biotech Ltd (BNR) |
| Form Type | 20-F |
| Filed Date | Apr 28, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 20-F, biotech
TL;DR
Burning Rock Biotech dropped its 2025 20-F. Check financials.
AI Summary
Burning Rock Biotech Ltd. filed its annual report on Form 20-F on April 28, 2026, for the period ending December 31, 2025. The filing includes various exhibits such as financial statements, tax information, and other supplementary documents. The company's principal executive offices are located in Guangzhou, Guangdong, China.
Why It Matters
This filing provides investors with the company's audited financial performance and operational details for the fiscal year 2025, crucial for understanding its financial health and future prospects.
Risk Assessment
Risk Level: medium — As a foreign private issuer, the company's reporting standards and regulatory environment may differ, and the filing itself is a routine annual disclosure without immediate new material information.
Key Numbers
- 3632066 — FORM 20-F iXBRL (Size of the main 20-F filing document in bytes.)
- 16108031 — Complete submission text file (Size of the complete submission text file in bytes.)
- 2608106 — EXTRACTED XBRL INSTANCE DOCUMENT (Size of the extracted XBRL instance document in bytes.)
Key Players & Entities
- Burning Rock Biotech Ltd (company) — Filer of the 20-F
- 0001792267 (company) — CUSIP number for Burning Rock Biotech Ltd
- 2026-04-28 (date) — Filing Date
- 2025-12-31 (date) — Period of Report
- NO. 5 XINGDAO RING ROAD NORTH, INTERNATIONAL BIO ISLAND GUANGZHOU, GUANGDONG China 510005 (location) — Mailing and Business Address
FAQ
What is the primary purpose of this 20-F filing?
The primary purpose of this 20-F filing is to serve as an annual report for Burning Rock Biotech Ltd., providing comprehensive financial and operational information for the fiscal year ending December 31, 2025.
When was this 20-F filing accepted by the SEC?
This 20-F filing was accepted by the SEC on April 28, 2026.
What is the period of report for this filing?
The period of report for this filing is December 31, 2025.
Where are Burning Rock Biotech Ltd.'s principal executive offices located?
Burning Rock Biotech Ltd.'s principal executive offices are located at NO. 5 XINGDAO RING ROAD NORTH, INTERNATIONAL BIO ISLAND GUANGZHOU, GUANGDONG China 510005.
What types of exhibits are included with this 20-F filing?
The filing includes various exhibits such as EX-8.1 (opinion of counsel), EX-12.1 and EX-12.2 (computations of ratios), EX-13.1 and EX-13.2 (financial information), EX-15.1 and EX-15.2 (other information), and XBRL financial data.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on April 28, 2026 regarding Burning Rock Biotech Ltd (BNR).